SC
VSTM icon

Sophrosyne Capital’s Verastem VSTM Stock Holding History

Sophrosyne Capital’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-9,252
Closed -$1.27M – 89
2013
Q4 		$1.27M Sell
9,252
-3,056
-25% -$402K 1.11% 28
2013
Q3 		$1.84M Sell
12,308
-6,279
-34% -$1.1M 1.22% 27
2013
Q2 		$3.1M Buy
+18,587
New +$2.24M 2.43% 16

Other funds holding VSTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Sophrosyne Capital's VSTM Position: Q1 2014 in Review

Sophrosyne Capital sold out of Verastem (VSTM) in Q1 2014, closing a stake of 9,252 shares — an estimated $1.27M sold.

Sophrosyne Capital first reported a position in VSTM in Q2 2013 and held it in 3 quarters. The position peaked at $3.1M in Q2 2013. 70 funds tracked by Wall St. Rank hold VSTM as of Q1 2014.

  • Sophrosyne Capital reported no remaining Verastem position as of Q1 2014 after selling out during the quarter.
  • Sophrosyne Capital sold 9,252 Verastem shares in Q1 2014, an estimated $1.27M.
  • Sophrosyne Capital first reported a position in Verastem in Q2 2013 and held it in 3 quarters.
  • Sophrosyne Capital's Verastem position peaked at $3.1M in Q2 2013.
  • 70 funds tracked by Wall St. Rank held Verastem as of Q1 2014.

Based on Sophrosyne Capital's 13F filing for Q1 2014, filed 14 May 2014.